Topical Corticosteroid Treatment of Dysphagia Due to Eosinophilic Esophagitis in Adults

2003 ◽  
Vol 78 (7) ◽  
pp. 830-835 ◽  
Author(s):  
Amindra S. Arora ◽  
Jean Perrault ◽  
Thomas C. Smyrk
Keyword(s):  
Topical Corticosteroid ◽  
Eosinophilic Esophagitis ◽  
Corticosteroid Treatment

1001 A Multivariable Model Predicts Complete Histologic Response to Topical Corticosteroid Treatment in Eosinophilic Esophagitis

2017 ◽  
Vol 85 (5) ◽  
pp. AB121
Author(s):  
Swathi Eluri ◽  
Irina Perjar ◽  
Johnathan Hollyfield ◽  
Spencer Rusin ◽  
John T. Woosley ◽  
...  
Keyword(s):  
Topical Corticosteroid ◽  
Eosinophilic Esophagitis ◽  
Corticosteroid Treatment ◽  
Multivariable Model ◽  
Histologic Response

Familial high serum PICP: high even in skin interstitial fluid, suppressible by topical corticosteroid treatment

2001 ◽  
Vol 314 (1-2) ◽  
pp. 153-157 ◽  
Author(s):  
Antti Sorva ◽  
Ritva Sorva ◽  
Juha Risteli ◽  
Leila Risteli ◽  
Pekka Autio
Keyword(s):  
Topical Corticosteroid ◽  
Interstitial Fluid ◽  
Corticosteroid Treatment ◽  
High Serum

scholarly journals Eosinophilic Esophagitis in Brazilian Pediatric Patients

2013 ◽  
Vol 7 ◽  
pp. CMPed.S12733 ◽  
Author(s):  
Mayra Isabel Correia Pinheiro ◽  
Luciano Pamplona De Góes Cavalcanti ◽  
Rodrigo Schuler Honório ◽  
Luïs Hélder De Alencar Moreno ◽  
Mayara Carvalho Fortes ◽  
...  
Keyword(s):  
Abdominal Pain ◽  
Topical Corticosteroid ◽  
Eosinophilic Esophagitis ◽  
Pediatric Patients ◽  
Erosive Esophagitis ◽  
Normal Mucosa ◽  
Patient Treatment ◽  
Therapeutic Approaches ◽  
Endoscopic Findings ◽  
The Mean

We examined 11 pediatric patients with eosinophilic esophagitis with a tardy diagnosis. The symptoms were initially thought to be related to other diseases, leading to the use of inadequate therapeutic approaches. The patients were between 3 and 17 years old (mean 7.8 ± 3.8 years), and 8 of the patients were male. Common symptoms included abdominal pain, regurgitation, difficulty in gaining weight, vomiting, dysphagia, and coughing. The mean age for the onset of symptoms was 4.3 ± 2.9 years. Endoscopic findings included normal mucosa in five (45%) patients, thickening of the mucosa with longitudinal grooves in three (27%), erosive esophagitis in two (18%), and a whitish stippling in one (9%) patient. Treatment included the use of a topical corticosteroid for 10 patients. In eight (73%) cases, the treatment made the symptoms disappear. Ten patients underwent histopathological management after treatment, with a decrease in the number of eosinophils.

Antimicrobial Silk Clothing in the Treatment of Atopic Dermatitis Proves Comparable to Topical Corticosteroid Treatment

Dermatology ◽  
2006 ◽  
Vol 213 (3) ◽  
pp. 228-233 ◽  
Author(s):  
G. Senti ◽  
L.S. Steinmann ◽  
B. Fischer ◽  
R. Kurmann ◽  
T. Storni ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Topical Corticosteroid ◽  
Corticosteroid Treatment

scholarly journals Clinical Outcome of Hypertensive Uveitis

2015 ◽  
Vol 2015 ◽  
pp. 1-6 ◽  
Author(s):  
Deborah Lewkowicz ◽  
François Willermain ◽  
Lia Judice Relvas ◽  
Dorine Makhoul ◽  
Sarah Janssens ◽  
...  
Keyword(s):  
Intraocular Pressure ◽  
Surgical Treatment ◽  
Clinical Outcome ◽  
Topical Corticosteroid ◽  
Retrospective Review ◽  
Corticosteroid Treatment ◽  
First Episode ◽  
Elevated Intraocular Pressure ◽  
Unilateral Disease

Purpose. To review the clinical outcome of patients with hypertensive uveitis.Methods. Retrospective review of uveitis patients with elevated intraocular pressure (IOP) > 25 mmHg and >1-year follow-up. Data are uveitis type, etiology, viral (VU) and nonviral uveitis (NVU), IOP, and medical and/or surgical treatment.Results. In 61 patients, IOP values are first 32.9 mmHg (SD: 9.0), highest 36.6 mmHg (SD: 9.9), 3 months after the first episode 19.54 mmHg (SD: 9.16), and end of follow-up 15.5 mmHg (SD: 6.24). Patients with VU (n=25) were older (50.6 y/35.7 y,p=0.014) and had more unilateral disease (100%/72.22%  p=0.004) than those with NVU (n=36). Thirty patients (49.2%) had an elevated IOP before topical corticosteroid treatment. Patients with viral uveitis might have higher first elevated IOP (36.0/27.5 mmHg,p=0,008) and maximal IOP (40.28/34.06 mmHg,p=0.0148) but this was not significant when limited to the measurements before the use of topical corticosteroids (p=0.260and 0.160). Glaucoma occurred in 15 patients (24.59%) and was suspected in 11 (18.03%) without difference in viral and nonviral groups (p=0.774).Conclusion. Patients with VU were older and had more unilateral hypertensive uveitis. Glaucoma frequently complicates hypertensive uveitis. Half of the patients had an elevated IOP before topical corticosteroid treatment.

Sign in / Sign up

Export Citation Format

Share Document